Last reviewed · How we verify

NCT04719741

Drug and Dose Adjustment in Preventing Postoperative Nausea and Vomiting

Status unknown Last updated 29 March 2022
What this trial tests

trial testing Parallel Assignment in Postoperative Nausea and Vomiting in 1,000 participants. Status unknown.

Timeline
1 May 2023
Primary endpoint
20 May 2024
20 August 2024

Quick facts

Lead sponsorJordan Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 May 2023
Primary completion20 May 2024
Estimated completion20 August 2024
Sites1 location across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

Jordan Hospital

Who can join

Adults 18 to 70, any sex, with Postoperative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to evaluate the effectiveness of different regimens of prophylactic Ondansetron, Dexamethasone, or both, on the incidence and severity of post-operative nausea and vomiting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Parallel Assignment

Trials testing the same drug.

Other recruiting trials for Postoperative Nausea and Vomiting

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing